Physician profile
Ken Stanley
NPI 1356493720
$3,691.25
in general payments reported to CMS, 2019-2025
26 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $595 · 2021: $408 · 2022: $326 · 2023: $611 · 2024: $589 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,492.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,674.74 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $535.46 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $234.15 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $201.46 | 2019-2023 | |
| Abbvie INC. | $182.06 | 2021-2025 | |
| Novo Nordisk INC | $166.56 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $91.47 | 2019-2023 | Vaxneuvance, M-M-R II, Gardasil 9 |
| Exact Sciences Corporation | $70.04 | 2023-2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $66.60 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $62.55 | 2020-2023 | |
| Lilly USA, LLC | $60.94 | 2023-2025 | Mounjaro, Zepbound, Emgality |
| Astellas Pharma US INC | $48.14 | 2019-2020 | |
| Zyla Life Sciences, INC. | $47.94 | 2019 | |
| Amarin Pharma, INC. | $36.32 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.77 | 2024 | Jardiance, Tradjenta |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $23.23 | 2024 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $20.61 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $20.00 | 2021 | |
| Hologic Sales and Service, LLC | $19.87 | 2021 | |
| Linus Health, INC. | $18.31 | 2022 | |
| Allergan, INC. | $18.12 | 2020 | |
| Sunovion Pharmaceuticals INC. | $16.41 | 2020 | |
| Medtronic, INC. | $15.75 | 2021 | |
| Currax Pharmaceuticals LLC | $12.98 | 2023 | Contrave |
| Radius Health, INC. | $11.88 | 2020 | |
| Sanofi Pasteur INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.